ClinConnect ClinConnect Logo
Search / Trial NCT07011875

The Effect of Physical Activity Levels on Dysmenorrhea Severity, Menstrual Symptoms, and Functional and Emotional Status in Women Diagnosed With Multiple Sclerosis

Launched by KARABUK UNIVERSITY · Jun 2, 2025

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Multiple Sclerosis Physical Activity Level Dysmenorrhea Severity Menstrual Symptom Functional And Emotional Status

ClinConnect Summary

Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune, and demyelinating disease that causes damage to the white matter of the central nervous system. It is typically seen between the ages of 20 and 40. The incidence of MS is reported to be three times higher in women than in men. Although its etiology is not definitively known, it is thought that a combination of genetic predisposition and a non-genetic trigger-such as a virus, metabolism, or environmental factors-leads to recurring immune attacks on the central nervous system, resulting in a self-sustaining autoimmune disorder.

...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female patients diagnosed with multiple sclerosis by a neurologist
  • Aged between 18 and 55 years
  • Having an active menstrual cycle
  • Having a regular menstrual cycle (24-35 days)
  • No physical or cognitive impairment that prevents participation in exercise
  • Willingness to participate in the study
  • Exclusion Criteria:
  • Postmenopausal status
  • Pregnancy or breastfeeding
  • Use of hormonal contraceptives or intrauterine devices
  • Use of medication that may affect dysmenorrhea
  • History of any gynecological surgery
  • Presence of pelvic pathology, pelvic inflammatory disease, endometriosis, or other conditions causing secondary dysmenorrhea

About Karabuk University

Karabuk University is a distinguished educational institution located in Turkey, dedicated to advancing scientific research and innovation across various fields, including healthcare. As a clinical trial sponsor, the university plays a pivotal role in facilitating cutting-edge research aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodology, Karabuk University collaborates with healthcare professionals and researchers to design and implement clinical trials that address pressing health challenges, ultimately striving to enhance treatment options and promote public health initiatives.

Locations

Karabük, , Turkey

Patients applied

0 patients applied

Trial Officials

Metehan YANA

Principal Investigator

Karabuk University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported